Price $4.26 |
Market Cap
180.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.52
|
P/S
-
|
Dividend %
-
|
|
P/CF
10.3
|
P/FCF
-
|
Op. Cash Flow
-51.5K
|
FCF
-1.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-90.60%
|
ROI
-58.30%
|
|
ROA
-62.10%
|
EPS Growth
1.30%
|
Current Ratio
6.4
|
Debt/Equity
13.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acer Therapeutics Inc (ACER) | $3.10 | - | - | 42.4M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.96 | - | - | 1.68B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $25.23 | - | - | 892.4M | Strong Buy |
| Arrowhead Pharmaceuticals Inc (ARWR) | $88.71 | - | - | 7.57B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $31.82 | - | - | 11.47B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
